nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoperazone—SLC22A11—Methotrexate—testicular cancer	0.304	0.304	CbGbCtD
Cefoperazone—SLC22A7—Methotrexate—testicular cancer	0.29	0.29	CbGbCtD
Cefoperazone—SLC22A8—Methotrexate—testicular cancer	0.177	0.177	CbGbCtD
Cefoperazone—SLC22A6—Methotrexate—testicular cancer	0.123	0.123	CbGbCtD
Cefoperazone—ALB—Methotrexate—testicular cancer	0.105	0.105	CbGbCtD
